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calculating correlations between the HoNOS and other 
scales. Secondly, we examined the differences between
HoNOS scores related to diagnoses and demographic pa-
rameters. Thirdly we calculated change criteria and outcome 
effect size for the HoNOS.  Results: Even in a small clinical 
sample (n = 100), the HoNOS-D items are highly correlated 
with the corresponding AMDP syndromes (p  ! 0.003). The 
HoNOS-D score is associated with the CGI score (p  ! 0.01). 
Correlations of HoNOS symptoms, behavior and impairment 
items with AMDP syndromes as well as differences in diag-
noses were appropriate and comprehensible as regards clin-
ical content, and change on the HoNOS total score is statisti-
cally significant (t = 6.57, d.f. = 89, p  ! 0.0001).  Conclusion: 
This study is the first to investigate the concurrent validity of 
HoNOS-D concerning psychopathology using the AMDP rat-
ing system in a clinical sample of patients with mental disor-
ders in an inpatient setting. HoNOS-D can be recommended 
for routinely screening outcomes in inpatient psychiatric 
settings. Our analysis showed that HoNOS-D covers psycho-
pathology corresponding to the AMDP rating system. A lim-
itation of the study is that the study sample comprised only 
an inpatient population; there may well be differences com-
pared to an outpatient sample. 
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 Abstract 
 Background: The Health of the Nation Outcome Scales
(HoNOS) were developed to assess the severity of a mental 
illness. They are used as outcome measures in different 
countries, and are meanwhile translated from the original 
English version into many languages, among others into 
German (HoNOS-D). We conducted a study in order to esti-
mate the concurrent validity and sensitivity to change using 
clinical parameters as ICD-10 diagnoses, as well as the Clini-
cal Global Impression Scale (CGI), and the Association for 
Methodology and Documentation in Psychiatry (AMDP) psy-
chopathology scale, a frequently used psychopathological 
rating system, in a representative clinical sample.  Sampling 
and Methods: Data on the three instruments (CGI, AMDP, 
HoNOS-D) were collected at admission and discharge of
100 psychiatric inpatients using a representative clinical 
sample. Experienced clinicians completed the CGI, AMDP 
and HoNOS-D. Descriptive and comparative data analyses 
were performed. We estimated the concurrent validity by 
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 Introduction 
 In the 1990s, the British Royal College of Psychiatrists 
developed the Health of the Nation Outcome Scales
(HoNOS), a comprehensive, easy-to-use instrument for 
assessing clinical outcome and severity of mental disor-
ders  [1–5] . There are versions for children and adoles-
cents, working-age adults, and over-65-year-olds  [6–8] . 
Mental health outcome measurement has hitherto fo-
cused on areas like symptom severity, personal function-
ing, quality of life, perceived needs and recovery  [9] .
Numerous instruments were developed for measuring 
global mental health status and social functioning. The 
Clinical Global Impression Scale (CGI) and the HoNOS 
are two such instruments. They are designed to be used 
within clinical populations, and are meant to be com-
pleted after a clinical evaluation. Van Os et al.  [10] point 
out that different aspects of the patients’ symptom pro-
file are related to different outcomes. They suggested
that outcome is becoming influenced by distinct psy-
chopathological dimensions independently and differ-
entially.
 The CGI is a standardized assessment tool, widely 
used in clinical psychopharmacology trials, as an out-
come measure with known qualities and shortcomings 
 [11–13] . The HoNOS was introduced in the 1990s as a 
more detailed mental health and psychosocial outcome 
measure. It consists of 12 items for the assessment of se-
verity of mental illness, deals with symptoms and dys-
functions, and is designed to track change over time. Psy-
chometric properties were found to be satisfactory for 
most of the items, but the authors of a review conclude 
that validity in psychiatric routine care warrants closer 
examination  [14] . Firstly, we tried to replicate the findings 
from evaluations of the validity of HoNOS and the Ger-
man version of HoNOS (HoNOS-D)  [11, 15, 16] by ex-
amining its association with the CGI as an established 
routine outcome measure. Secondly, we tested the con-
current validity concerning psychopathology using the 
Association for Methodology and Documentation in 
Psychiatry (AMDP) rating system  [17–21] . This instru-
ment is used for standardized clinical assessment of psy-
chopathology and is widely used in German-speaking 
countries. It has been developed in Europe by the Asso-
ciation for Methodology and Documentation in Psychia-
try and allows the user to calculate psychopathological 
syndromes out of 140 symptoms. It corresponds to
classical psychopathological concepts, and is useful not 
only in the measurement of change, but also in teaching 
and standardization of the clinical documentation  [20] . 
Thirdly, we examined the HoNOS sensitivity of change 
in an inpatient sample. The aim of the present study was 
to examine the value of the HoNOS-D in a clinical inpa-
tient context by analyzing the concurrent validity in rela-
tion to two established clinical scales that are frequently 
used in German-speaking countries. Our hypothesis was 
that HoNOS scores are associated with clinical global im-
pression rated on the CGI, as well as with psychopathol-
ogy measured by the AMDP rating system. As some of 
the HoNOS items target psychopathological symptoms 
similar to those rated on the AMDP rating system, we 
hypothesized that those items would highly correlate 
with the respective AMDP syndrome subscales.
 Methods 
 Subjects 
 The study sample comprised 100 individuals admitted to the 
Psychiatric University Hospital of Zurich over a period of 10 
months in 2009. Participants had to fulfill the following criteria: 
any psychiatric diagnosis according to ICD-10 except substance 
abuse and organic psychiatric disorder, and age between 18 and 
65 years. Participants had to give written informed consent. Fifty-
five percent of the inpatient sample was male. The mean age was 
42 years (SD 12, range 19–65). The main diagnosis, i.e. the ICD-10 
diagnosis that determined the current treatment regimen, was re-
corded  [22] . The largest diagnostic groups were schizophrenic 
disorders (F2) with 37% followed by mood disorders (F3) with 
33%, anxiety and stress disorders (F4) with 17% and personality 
disorders (F6) with 13%. The average duration of treatment for the 
patients was 30 days (SD 20, range 3–128).
 Experienced clinicians completed the HoNOS-D  [15] , CGI 
 [23] , and the AMDP rating system  [24] at admission and dis-
charge relying on direct observation, interviews with patients, 
and information obtained from medical records.
 Instruments 
 The HoNOS-D contains 12 items, each scored from 0 to 4. The 
severity of each problem is rated from ‘no problem’ to ‘severe or 
very severe problem’. The total score, which represents overall se-
verity, ranges between 0 and 48. It was suggested that the scale 
could be subdivided into 4 subscales (‘behavioral problems’, ‘im-
pairment’, ‘symptomatic problems’ and ‘social problems’). How-
ever, there is not really much evidence that subscale scores are 
reliable  [14, 16, 25, 26] . Therefore, we only used the HoNOS-D 
main score and single items for further calculations. The CGI pro-
vides the severity of illness score for the assessment of patients’ 
current symptom severity and it measures change over time. The 
CGI consists of 3 global subscales: the severity of illness subscale, 
the global improvement subscale and the efficacy index. The se-
verity of illness subscale scores range from 1 (‘not ill’) to 7 (‘ex-
tremely ill’). The global improvement subscale scores go from 1 
(‘very much improved’) to 7 (‘very much worse’). The efficacy in-
dex scores range from 0 (‘marked improvement’) to 4 (‘unchanged 
or worse’). The AMDP rating scale consists of 140 items equaling 
psychopathological symptoms rated on a 5-point scale (absent-
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mild-moderate-severe-extremely severe)  [11] . A number of syn-
dromes can be composed out of up to 13 AMDP items each, i.e. 
paranoid-hallucinatory, depressive, psychoorganic, maniac, hos-
tility, autonomic, apathy and obsessive-compulsive syndrome.
 The HoNOS-D and CGI were completed on 100 subjects at 
admission, and on 90 subjects at discharge, and the AMDP rating 
system on 96 subjects at admission and discharge.
 The study was approved by the ethics committee of the medi-
cal faculty of the University of Zurich. All patients gave written 
informed consent prior to study inclusion. This study was per-
formed in accordance with the ethical standards laid down in the 
1964 Declaration of Helsinki.
 Statistical Analysis 
 The data were analyzed with SPSS 15.0 for Windows software 
(SPSS Inc., Chicago, 2006)  [27] . Descriptive analyses were used to 
examine clinical and demographic characteristics, as well as the 
statistical properties of scales. Since distributions of raw scores on 
AMDP syndrome scales were highly skewed with a large propor-
tion of subjects showing little pathology, associations of AMDP 
syndrome subscales and HoNOS-D items were analyzed by Spear-
man’s rank order correlation. Due to the high number of com-
parisons the level of significance was adjusted to p = 0.003 to
avoid alpha error accumulation. CGI and HoNOS-D correlations 
were calculated by using Pearsons’ r coefficients. Differences in 
HoNOS item and total scores between diagnostic groups, age and 
gender were calculated using the t test. Due to multiple testing the 
level of significance was adjusted to p = 0.004 according to Bon-
ferroni.
 Results 
 The analyzed data showed an association between the 
mean HoNOS-D total score at admission and the CGI 
severity index at admission (r = 0.201, p = 0.045). The 
HoNOS-D at discharge correlated highly with the CGI 
severity index at discharge (r = 0.347, p = 0.001). The cor-
relation between the mean HoNOS difference total scores 
(admission total score minus discharge total score) and 
CGI improvement score was r = 0.257 and p = 0.014.
 Mean scores on the HoNOS-D items at admission 
were distributed as depicted in  table 1 [mean scores range 
from 0 (no problem) to 4 (severe problem)]. There were no 
missing values for individual HoNOS-D items.
 Concurrent validity was tested by correlating HoNOS-
D items 1–12 with AMDP syndromes.  Table 2 shows that 
HoNOS-D items are highly correlated with the corre-
sponding AMDP syndromes as regards clinical content. 
As expected, the highest coefficients (Spearman’s rho 
 1 0.4) were found in correlations of HoNOS-D items with 
clinically corresponding AMDP syndromes: aggression/
agitation and hostility/mania syndrome, cognitive dys-
function and psychoorganic syndrome, hallucinations/
delusions and paranoid-hallucinatory syndrome, as well 
as depression and depressive syndrome.
 Mean HoNOS scores and change scores are shown in 
 table 3 . The presented outcome effect sizes are calculated 
by dividing the change score by the standard deviation of 
the assessment score. Change on HoNOS total score is 
statistically significant (t = 6.57, d.f. = 89, p  ! 0.0001) with 
a pre-post effect size of 0.92. Items 5 (p = 0.24), 9 (p = 
0.06), and 11 (p = 0.2) showed change scores that were not 
significant at the p  ! 0.05 level.
 Neither the HoNOS total score nor the CGI severity 
index differed in relation to the diagnostic groups ac-
cording to ICD-10. In our sample, males (n = 55) had sig-
nificantly higher ratings on ‘overactivity, aggression’ 
(mean = 1.09, SD = 1.19) than females (mean = 0.62,
SD = 0.91; t = 2.22, p = 0.028). Females (n = 45) had sig-
nificantly higher ratings on ‘self-harm’ (mean = 0.76,
SD = 1.38) than males (mean = 0.22, SD = 0.78; t = –2.32, 
p = 0.024). There were no gender differences regarding 
the remaining items and the HoNOS mean total score.
 Patients over 41 years (median age) had significantly 
higher ratings on ‘physical disability’ compared to young-
er individuals (mean = 1.17, SD = 1.43; t = –2.64, p =
0.01). They had lower scores on ‘hallucinations/delusions’ 
(mean = 1.06, SD = 1.45; t = 1.82, p = 0.072), ‘problems 
with personal relationships’ (mean = 2.02, SD = 1.23);
t = 2.11, p = 0.037), ‘problems with overall functioning’ 
(mean = 2.02, SD = 1.00; t = 3.25, p = 0.02), ‘occupational 
problems’ (mean = 1.69, SD = 1.00; t = 3.25, p = 0.02) and 
‘total score’ (mean = 19.17, SD = 6.42; t = 2.35, p = 0.021).
Table 1.  Distribution characteristics of the items of HoNOS-D (at 
admission, mean 8 SD; n = 100)
Item Label Mean 8 SD
1 Aggression 0.8881.1
2 Self-harm 0.4681.12
3 Substance use 0.8081.48
4 Cognitive dysfunction 1.1881.18
5 Physical disability 0.8281.28
6 Hallucinations/delusions 1.3881.72
7 Depression 2.6981.16
8 Other symptoms 3.2281.35
9 Problems with personal relationships 2.2781.15
10 Problems with overall functioning 2.3681.05
11 Residential problems 1.3081.88
12 Occupational problems 2.1481.37
1–12 HoNOS-D total sum 20.5985.95
1–12 HoNOS-D total mean 1.7280.50
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 We analyzed the diagnostic groups [‘schizophrenia’
(n = 37), ‘mood disorders’ (n = 33), ‘neurotic, stress-relat-
ed and somatoform disorders’ (n = 17) and ‘disorders of 
adult personality and behavior’ (n = 13)] regarding the 
HoNOS scores and found that patients with a schizophre-
nia diagnosis according to ICD-10 showed significantly 
higher scores for ‘aggression, overactivity’ (p = 0.003), 
‘cognitive dysfunction’ (p  ^  0.0001) and ‘hallucinations, 
delusions’ (p  ^  0.0001). They showed lower scores on 
‘self-harm’ (p = 0.007), ‘physical’ (p = 0.003) and ‘depres-
sion’ (p = 0.06).
 Patients in the mood disorder group had higher scores 
for ‘depression’ (p = 0.091), ‘physical disability’ (p = 0.047) 
and lower scores for ‘aggression, overactivity’ (p = 0.001), 
‘cognitive dysfunction’ (p = 0.015), and ‘hallucinations, 
delusions’ (p  ! 0001). Patients with a neurotic, stress-re-
lated and somatoform diagnosis showed significantly 
lower scores for ‘cognitive dysfunction’ (p = 0.04).
 Discussion 
 The present paper reports findings concerning the 
concurrent validity of the German version of the HoNOS 
in relation to an established psychiatric outcome scale 
and a measure for psychopathological rating. In this 
study, we were able to show that HoNOS-D items are 
highly correlated with the corresponding AMDP syn-
dromes. To our knowledge, this is the first report regard-
ing the concurrent validity tested with the AMDP rating 
system. Due to different psychopathological traditions 
and the widespread use of the instrument, we decided to 
employ the AMDP rating system for testing concurrent 
validity. Additionally, we assessed the differences in
HoNOS items and total scores between diagnostic groups 
according to ICD-10. Correlations of HoNOS symptoms, 
behavior and impairment items with AMDP syndromes 
as well as differences in diagnoses were appropriate and 
comprehensible as regards clinical content. As such we 
suggest that the HoNOS has moderate concurrent valid-
ity in covering psychopathology and clinical status. Oth-
er authors tested concurrent validity with the Brief Psy-
chiatric Rating Scale, the Positive and Negative Syndrome 
Scale and other instruments  [2, 28, 29] . Basically, the
HoNOS seemed to perform well; however, there are ex-
ceptions with a low correlation being found  [30] between 
the HoNOS and the Brief Psychiatric Rating Scale. Con-
sidering that there were no missing values for any
HoNOS item in this small sample it would seem to be ap-
propriate to claim a good feasibility at least in an inpatient 
population, due to the good availability of information 
(direct observation, interviews with patients and infor-
mation obtained from medical records).
 According to our hypothesis and to prior findings 
there was a significant correlation between the CGI and 
HoNOS-D  [11, 31] .
Table 2.  Correlation matrix of HoNOS-D scale and items with AMDP syndromes (Spearman’s rank order correlation; n = 96)
AMDP PARHAL DEPRES PSYORG MANI HOST VEGET APA OBCOM
HoNOS 0.352** 0.213 0.224 0.230 0.074 0.206 0.092 0.342** 0.110
Aggression/agitation 0.137 0.318** –0.208 0.193 0.379** 0.415** –0.024 0.026 0.040
Self-harm 0.153 –0.052 0.238 –0.014 –0.020 –0.021 0.104 0.156 0.111
Substance use –0.002 –0.062 0.047 –0.072 0.075 –0.093 –0.094 0.091 –0.045
Cognitive dysfunction 0.212 0.330** –0.169 0.509** 0.095 0.203 –0.079 0.235 0.014
Physical disability 0.082 –0.119 0.200 –0.019 0.050 0.041 0.251 0.028 –0.043
Hallucinations/delusions 0.244 0.675** –0.240 0.324** 0.046 0.096 0.015 0.149 0.145
Depression 0.256 –0.180 0.541** –0.014 –0.298** –0.083 0.110 0.212 0.158
Other symptoms –0.017 –0.159 0.177 –0.077 –0.106 –0.029 0.090 –0.019 0.091
Personal relationships 0.326* 0.088 0.258 0.105 0.060 0.185 0.186 0.222 0.074
Overall functioning 0.337* 0.132 0.230 0.202 –0.051 0.218 0.180 0.371** 0.026
Residential problems 0.068 0.182 0.021 –0.027 0.068 –0.016 0.023 0.183 –0.111
Occupational problems 0.017 –0.115 0.106 0.024 –0.075 0.114 0.103 0.200 –0.012
* * p < 0.003; * p = 0.001. 
PARHAL = Paranoid-hallucinatory syndrome; DEPRES = depressive syndrome; PSYORG = psychoorganic syndrome; MANI = 
maniac syndrome; HOST = hostility syndrome; VEGET = autonomic syndrome; APA = apathy syndrome; OBCOM = obsessive-com-
pulsive syndrome.
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 In a previous publication, the authors reported the 
correlation between the direct measure of CGI improve-
ment scores and the indirect measure by comparing the 
admission and discharge CGI severity ratings that reflect 
sensitivity to change  [11] . In our sample, HoNOS sensitiv-
ity to change assessed by rating patients at admission and 
discharge ( table 3 ) shows limitations in comparison with 
the CGI. Comparable to Audin et al.  [32] and Andreas et 
al.  [16] , items 7 and 10 showed medium values, and the 
majority of the items and the HoNOS total score proved 
to be moderately sensitive to change, although our sam-
ple differs from their sample with regard to 37% of the 
participants having a schizophrenia diagnosis. Item 11 
(‘residential problems’) has to be understood in the con-
text of the average duration of treatment (30 days), chang-
es in this timeframe not being likely.
 Our sample showed a higher HoNOS mean score 
(20.59) than other studies  [2, 32] . A number of gender and 
age effects were found. Males had significantly higher 
ratings on ‘overactivity, aggression’ and lower ones on 
‘self-harm’ than females. Patients over 41 years had sig-
nificantly higher ratings on ‘physical disability’ and low-
Table 3.  HoNOS and CGI change data
Item N Mean 8 SD Change 
score
95% CI 
change
Paired samples 
t test
Outcome 
effect size
1 a
d
90 0.8981.07
0.5780.91
0.32 0.08–0.57 t = 2.61, d.f. = 89
p = 0.01
0.30
2 a
d
90 0.4981.16
0.1480.61
0.34 0.12–0.56 t = 3.11, d.f. = 89
p = 0.01
0.29
3 a
d
90 0.7381.23
0.2680.76
0.47 0.25–0.69 t = 4.26. d.f. = 89
p < 0.0001
0.38
4 a
d
90 1.1981.13
0.9181.05
0.28 0.06–0.49 t = 2.59. d.f. = 89
p = 0.01
0.25
5 a
d
90 0.7981.25
0.6781.06
0.12 –0.08 to 0.33 t = 1.18. d.f. = 89
p = 0.24
0.10
6 a
d
90 1.4081.70
0.8181.40
0.59 0.33–0.85 t = 4.52. d.f. = 89
p < 0.0001
0.35
7 a
d
90 2.6781.20
1.6281.04
1.04 0.79–1.30 t = 8.20. d.f. = 89
p < 0.0001
0.87
8 a
d
90 4.3382.41
3.6182.81
0.72 0.22–1.22 t = 2.88. d.f. = 89
p = 0.005
0.30
9 a
d
90 2.2681.18
1.9881.28
0.28 –0.01 to 0.57 t = 1.88. d.f. = 89
p = 0.06
0.24
10 a
d
90 2.3381.07
1.6981.06
0.64 0.38–0.90 t = 4.93. d.f. = 89
p < 0.0001
0.60
11 a
d
90 1.3681.93
1.0681.49
0.30 –0.16 to 0.76 t = 1.29. d.f. = 89
p = 0.2
0.15
12 a
d
90 2.1781.35
1.6281.41
0.54 0.26–0.83 t = 3.80. d.f. = 89
p < 0.0001
0.4
Total a
d
90 20.5986.14
14.9387.87
5.66 3.94–7.37 t = 6.57. d.f. = 89
p < 0.0001
0.92
CGI a
d
100 5.9380.73
4.9380.99
1.00 0.79–0.79 t = 9.57. d.f. = 99
p < 0.0001
1.37
a = Admission; d = discharge.
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